Literature DB >> 32038976

Dosimetric and clinical factors predicting quality of life after post prostatectomy radiation therapy: useful tool or not?

Christian Carrie1, Gabriel Bringeon2.   

Abstract

Year:  2019        PMID： 32038976      PMCID： PMC6987596          DOI： 10.21037/tau.2019.08.04

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN： 2223-4683


× No keyword cloud information.
  4 in total

1.  Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.

Authors:  William U Shipley; Wendy Seiferheld; Himanshu R Lukka; Pierre P Major; Niall M Heney; David J Grignon; Oliver Sartor; Maltibehn P Patel; Jean-Paul Bahary; Anthony L Zietman; Thomas M Pisansky; Kenneth L Zeitzer; Colleen A F Lawton; Felix Y Feng; Richard D Lovett; Alexander G Balogh; Luis Souhami; Seth A Rosenthal; Kevin J Kerlin; James J Dignam; Stephanie L Pugh; Howard M Sandler
Journal:  N Engl J Med       Date:  2017-02-02       Impact factor: 91.245

2.  Clinimetrics Corner: The Minimal Clinically Important Change Score (MCID): A Necessary Pretense.

Authors:  Chad E Cook
Journal:  J Man Manip Ther       Date:  2008

3.  Patient-reported Outcomes and Late Toxicity After Postprostatectomy Intensity-modulated Radiation Therapy.

Authors:  Adil S Akthar; Chuanhong Liao; Scott E Eggener; Stanley L Liauw
Journal:  Eur Urol       Date:  2019-05-19       Impact factor: 20.096

4.  Salvage radiotherapy for patients with rising PSA - Authors' reply.

Authors:  Christian Carrie; Sophie Dussart
Journal:  Lancet Oncol       Date:  2016-08       Impact factor: 41.316
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.